U.S. Markets closed

Biogen Inc. (BIIB)


NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
253.33+5.23 (+2.11%)
At close: 4:00PM EDT

253.00 -0.33 (-0.13%)
After hours: 6:53PM EDT

People also watch
CELGREGNGILDAMGNALXN
Interactive chart
Previous Close248.10
Open249.30
Bid249.95 x 100
Ask254.70 x 100
Day's Range246.12 - 254.37
52 Week Range223.02 - 333.65
Volume2,011,176
Avg. Volume1,557,233
Market Cap54.12B
Beta0.51
PE Ratio (TTM)15.87
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Reuters2 hours ago

    Deadly brain infection in German MS patient prompts Roche investigation

    A person in Germany treated with Roche Holding AG’s new multiple sclerosis drug Ocrevus has been diagnosed with an often-deadly brain infection after switching from another medication earlier this year, the Swiss drugmaker said on Wednesday. Roche said it was investigating a case of Progressive Multifocal Leukoencephalopathy (PML) in a patient previously being treated for three years with Biogen Inc’s Tysabri and who had received a single dose of Ocrevus in February. Roche is trying to determine the source of the illness but MS drugs that suppress the immune system can increase the risk of serious infections.

  • Biogen Spinoff Bioverativ Squares Off With Roche After $400 Million Buy
    Investor's Business Daily4 hours ago

    Biogen Spinoff Bioverativ Squares Off With Roche After $400 Million Buy

    Bioverativ stock popped Wednesday after the Biogen spinoff announced a $400 million acquisition of True North Therapeutics.

  • Biotech And Pharma Industry And Stock News
    Investor's Business Daily4 hours ago

    Biotech And Pharma Industry And Stock News

    Track the latest trends and leading stocks in the biotech and pharmaceutical industries.